North America Fat Reduction Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2024 –2033 |
 Marktgröße (Basisjahr) | |
 Marktgröße (Prognosejahr) | USD 11,773.56 |
 CAGR |
% |
| Wichtige Marktteilnehmer |
>Nordamerikanischer Markt für Fettreduktion, nach Typ (chirurgische Fettreduktion, nichtinvasive Fettreduktion und minimalinvasiv), Anwendung (Bauchfett, Oberschenkelfett, Gesäßfett, Oberarmfett, Gesichtsfettdepots und Kniefett), Geschlecht (weiblich und männlich), Altersgruppe (Erwachsene, Senioren und Kinder), Endverbraucher (Krankenhäuser, Kliniken für mehrere Fachrichtungen, dermatologische Zentren, medizinische Spas und Schönheitszentren und andere), Vertriebskanal (direkte Ausschreibung, Einzelhandelsverkäufe, Drittanbieter und andere), Branchentrends und Prognose bis 2033.
Marktanalyse und Einblicke zur Fettreduzierung in Nordamerika
Der nordamerikanische Markt für Fettreduktion wird im Prognosezeitraum voraussichtlich wachsen, da die Nachfrage nach minimalinvasiven und nichtinvasiven Verfahren steigt und die Unterschiede zwischen Männern und Frauen bei ästhetischen Funktionen abnehmen. Der Markt wird auch durch das wachsende ästhetische Bewusstsein und die Schönheitsstandards sowie den zunehmenden technologischen Fortschritt beeinflusst. Der nordamerikanische Markt für Fettreduktion wird jedoch voraussichtlich durch die hohen Kosten der Verfahren, die mit den Verfahren verbundenen erhöhten Risiken und Produktrückrufe beeinträchtigt.
Die maßgeschneiderten Behandlungspläne und die Integration mit anderen ästhetischen Verfahren, Überzeugungen und Trends der Fettreduzierung bei jungen Erwachsenen sowie der Fokus auf Inklusivität und Vielfalt und die Erweiterung der Produktlinien werden voraussichtlich Chancen für Marktwachstum bieten. Die geringe langfristige Wirksamkeit und Nachhaltigkeit sowie die längere Erholungszeit des Verfahrens dürften jedoch das Marktwachstum bremsen.
Die Nachfrage nach Fettreduktionsprodukten ist sowohl in Industrie- als auch in Entwicklungsländern gestiegen. Der Grund dafür ist ihre Wirksamkeit und Verfügbarkeit. Daher bieten viele Marktteilnehmer Fettreduktionsprodukte mit Innovationen an, die den Weg für das Wachstum des nordamerikanischen Fettreduktionsmarktes ebnen.
Laut einer Analyse von Data Bridge Market Research dürfte der nordamerikanische Markt für Fettreduktion bis 2033 einen Wert von 11.773,56 Millionen US-Dollar erreichen, was einer durchschnittlichen jährlichen Wachstumsrate (CAGR) von 9,9 % während des Prognosezeitraums entspricht.
|
Berichtsmetrik |
Details |
|
Prognosezeitraum |
2023 bis 2033 |
|
Basisjahr |
2022 |
|
Historische Jahre |
2021 (anpassbar auf 2015–2020) |
|
Quantitative Einheiten |
Umsatz in Mio. USD |
|
Abgedeckte Segmente |
Typ (Chirurgische Fettreduktion, nicht-invasive Fettreduktion und minimal-invasiv), Anwendung (Bauchfett, Oberschenkelfett, Gesäßfett, Oberarmfett, Gesichtsfettdepots und Kniefett), Geschlecht (weiblich und männlich), Altersgruppe (Erwachsene, geriatrische Patienten und Kinder), Endverbraucher (Krankenhäuser, Kliniken mit mehreren Fachrichtungen, dermatologische Zentren, medizinische Spas und Schönheitszentren und andere), Vertriebskanal (Direktausschreibung, Einzelhandelsverkauf, Drittvertrieb und andere) |
|
Abgedeckte Länder |
USA, Kanada, Mexiko, Costa Rica, Dominikanische Republik, Panama, El Salvador, Guatemala, Honduras und Nicaragua |
|
Abgedeckte Marktteilnehmer |
Hironic Co Ltd, AbbVie Inc., Cynosure, Alma Lasers, Candela Corporation, Merz Pharma, Solta Medical (Tochtergesellschaft von Bausch & Lomb Incorporated), Cutera, MicroAire Surgical Instruments, LLC., Mentor Worldwide LLC, Venus Concept, Erchonia Corporation, BTL Group of Companies, Leaderma Inc., MÖLLER Medical, Fotona und Implantech., um nur einige zu nennen. |
Definition des nordamerikanischen Fettreduktionsmarktes
Fettabbau bezieht sich auf die Reduzierung der Körperfettmenge oder des Fettgewebes im Körper einer Person. Dabei werden Strategien und Techniken eingesetzt, die darauf abzielen, den Gewichtsverlust zu fördern und den Gesamtanteil des Körperfetts zu verringern. Der Körperfettabbau kann durch chirurgische und nicht-chirurgische Verfahren erfolgen. Es stehen verschiedene Behandlungen zur Verfügung, wie Laserlipolyse, Kryolipolyse, Fettabsaugung, Injektionsbehandlung und andere.
Marktdynamik für Fettreduktion in Nordamerika
In diesem Abschnitt geht es um das Verständnis der Markttreiber, Vorteile, Chancen, Einschränkungen und Herausforderungen. All dies wird im Folgenden ausführlich erläutert:
Treiber
- Steigende Nachfrage nach minimalinvasiven und nichtinvasiven Eingriffen
Die Anwendung minimalinvasiver und nichtinvasiver Verfahren hat sich gegenüber traditionellen Methoden zur Fettreduktion, einschließlich Laser und anderer energiebasierter Geräte, verschoben. Für die Anwendung chirurgischer oder nichtchirurgischer Verfahren wurden speziell für die minimalinvasiven Verfahren konzipierte Instrumente entwickelt.
Minimalinvasive Chirurgie ist ein Verfahren, das mit Hilfe eines Sichtfelds und speziell ausgestatteter chirurgischer Instrumente durchgeführt wird. Bei minimalinvasiven Verfahren sind keine oder nur minimale Schnitte erforderlich, und die Genesungszeit ist kürzer, was zu einer steigenden Nachfrage und Verwendung minimalinvasiver Verfahren führt. Weitere Gründe für den Anstieg der Verfahren sind die zunehmende Alterung der Bevölkerung und der Bedarf an Gesundheitseinrichtungen, einschließlich patientenfreundlicher Techniken, deren medizinische Anforderungen maximal sind, was zu einer weiteren Verringerung der Belastung der Gesundheitseinrichtungen führen kann.
Die minimalinvasiven/nichtinvasiven Verfahren sind auf den Komfort des Patienten ausgerichtet. Sie haben fast keine Nebenwirkungen und die Genesungszeit ist sehr kurz. Daher fühlen sich die Menschen wohler, wenn sie sich einem Eingriff zur ästhetischen Verbesserung unterziehen. Daher wird erwartet, dass die erhöhte Nachfrage nach minimalinvasiven und nichtinvasiven Verfahren als Treiber für den Markt wirken wird.
Zurückhaltung
- Hohe Verfahrenskosten
Auf moderner Technologie basierende Fettreduktionsgeräte helfen dabei, verschiedene Körperteile zu straffen und zu festigen, indem sie Fett mithilfe technologisch fortschrittlicher Methoden wie ultraschallbasierten, lasergestützten oder radiofrequenzgestützten Fettreduktionsgeräten reduzieren. Die Kosten der Fettreduktion variieren erheblich von Ort zu Ort oder von Region zu Region. Zu den wichtigsten Faktoren, die die Kosten der Fettreduktion bestimmen, gehören unter anderem Faktoren wie die für den Eingriff ausgewählte medizinische Einrichtung oder Klinik, der Behandlungsbereich, der betroffene Bereich, die Aufenthaltsdauer des Patienten und die Komplexität des chirurgischen Eingriffs. Die hohen Kosten des Eingriffs sind auf die verschiedenen Kontrollpunkte des chirurgischen Eingriffs sowie die Verwendung hochtechnologischer Methoden zur Durchführung solcher Eingriffe zurückzuführen. Da die Kosten technologisch fortschrittlicher Fettreduktionsgeräte hoch sind, steigen die Kosten des Eingriffs proportional an, weshalb die hohen Kosten des Eingriffs voraussichtlich die Nachfrage des Marktes beeinträchtigen werden.
Gelegenheit
- Individuelle Behandlungspläne und Integration mit anderen ästhetischen Verfahren
Durch individuelle Behandlungspläne und die Integration von Fettreduktionsverfahren in andere ästhetische Behandlungen können Unternehmen auf dem nordamerikanischen Fettreduktionsmarkt maßgeschneiderte Lösungen anbieten und das Gesamtbehandlungserlebnis für ihre Kunden verbessern. Diese Strategien optimieren nicht nur die Ergebnisse, sondern zeigen auch das Engagement, individuelle Bedürfnisse und Vorlieben zu erfüllen, was die Kundenzufriedenheit und -treue fördert. Daher wird erwartet, dass individuelle Behandlungspläne und die Integration in andere ästhetische Verfahren eine Chance für das Wachstum des Marktes schaffen.
Herausforderung
- Langfristige Wirksamkeit und Nachhaltigkeit
Die Behandlungsergebnisse können von Faktoren wie Stoffwechsel, Genetik und Lebensstil beeinflusst werden. Während manche Menschen dramatischere und langanhaltendere Erfolge erzielen, benötigen andere möglicherweise mehr Sitzungen oder zusätzliche Behandlungen, um die gewünschten Ergebnisse zu erzielen. Die Aufrechterhaltung der langfristigen Wirksamkeit stellt auch bei hartnäckigen Fettablagerungen ein Problem dar. Behandlungen zur Reduzierung des Körperfetts können an bestimmten Körperteilen, wie dem Unterbauch oder den Hüftspeck, weniger wirksam sein.
Die langfristige Wirksamkeit und Nachhaltigkeit stellen auf dem nordamerikanischen Markt für Fettreduktion eine große Herausforderung dar und werden voraussichtlich das Wachstum des Marktes bremsen.
Jüngste Entwicklungen
- Im Oktober 2023 wird MOLLER Medical vom 1. bis 3. Juni 2023 eine Veranstaltung namens SOFCEP Congress 2023 organisieren. Das Thema dieser Veranstaltung ist ästhetische Medizin und die Komplementarität zwischen Gesten und Eingriffen der ästhetischen Medizin. Dies würde dem Unternehmen helfen, einen größeren Kundenstamm zu erreichen.
- Im August 2023 wird Implantech die Veranstaltung im Rahmen der zweiten multidisziplinären Ästhetikkonferenz im Marriot Marquis Hotel in San Diego, USA, organisieren. Diese Konferenz soll dem Unternehmen dabei helfen, seine Innovationen im Bereich Implantate zu präsentieren.
- Im Mai 2023 gab Hironic Co., Ltd. bekannt, dass es bei den „2023 Consumer Satisfaction Awards“ von Money Today, die am 27. im Korea Press Center in Jung-gu, Seoul, stattfanden, den Hauptpreis in der Kategorie Schönheits- und Medizingeräte gewonnen habe. Dies hilft dem Unternehmen unter anderem dabei, sein Markenimage zu entwickeln.
- Im Januar 2023 gab Fotona bekannt, dass es auf dem IMCAS-Kongress sein Produktportfolio im Bereich Ästhetik vorstellte. Es gab an, dass sein Ästhetikportfolio, das SP Dynamis Nx Line-Lasersystem mit integrierter CoolMist-Hautkühlung und optionaler Dynamic Vacuum Technology sowie andere Produkte und Anwendungen von Fotona wie AvalancheLase, TimeWalker Fotona4D vorgestellt wurden, die dem Unternehmen helfen würden, einen größeren Kundenstamm zu erreichen.
- Im Juni 2019 brachte Cutera sein neues Produkt namens truSculpt Flex für den Muskelformungsmarkt auf den Markt. Dieses neue Produkt des Unternehmens erweitert sein Produktportfolio im medizinisch-ästhetischen Segment, was zu einer erhöhten Nachfrage nach seinem Produkt auf dem Markt führt.
Marktumfang für Fettreduzierung in Nordamerika
Der nordamerikanische Markt für Fettreduktion ist in sechs wichtige Segmente unterteilt, nämlich Typ, Anwendung, Geschlecht, Altersgruppe, Endverbraucher und Vertriebskanal. Das Wachstum zwischen den Segmenten hilft Ihnen, Nischenwachstumsbereiche und Strategien zur Marktansprache zu analysieren und Ihre wichtigsten Anwendungsbereiche und die Unterschiede in Ihren Zielmärkten zu bestimmen.
Typ
- Chirurgische Fettreduktion
- Nicht-invasive Fettreduktion
- Minimal Invasiv
Basierend auf dem Typ ist der nordamerikanische Markt für Fettreduktion in chirurgische Fettreduktion, nicht-invasive Fettreduktion und minimal-invasive Fettreduktion segmentiert.
Anwendung
- Bauchfett
- Oberschenkel Fett
- Gesäßfett
- Oberarmfett
- Gesichtsfett-Ablagerungen
- Kniefett
Basierend auf der Anwendung ist der nordamerikanische Markt zur Fettreduktion in Bauchfett, Oberschenkelfett, Gesäßfett, Oberarmfett, Gesichtsfettdepots und Kniefett segmentiert.
Geschlecht
- Weiblich
- Männlich
Basierend auf dem Geschlecht ist der nordamerikanische Markt zur Fettreduktion in männlich und weiblich segmentiert.
Altersgruppe
- Erwachsene
- Geriatrie
- Kind
Basierend auf den Altersgruppen ist der nordamerikanische Markt für Fettreduktion in Erwachsene, Senioren und Kinder segmentiert.
Endbenutzer
- Krankenhäuser
- Kliniken mit mehreren Fachrichtungen
- Dermatologische Zentren
- Medizinische Spas und Schönheitszentren
- Sonstiges
Basierend auf dem Endverbraucher ist der nordamerikanische Markt zur Fettreduktion in Krankenhäuser, Kliniken mit mehreren Fachrichtungen, dermatologische Zentren, medizinische Spas und Schönheitszentren segmentiert.
Vertriebskanal
- Direkte Ausschreibung
- Einzelhandelsumsätze
- Drittanbieter
- Sonstiges
Basierend auf dem Vertriebskanal ist der nordamerikanische Markt zur Fettreduktion in Direktausschreibungen und Einzelhandelsverkäufe, Drittanbieter und Sonstiges segmentiert.
Nordamerika: Regionale Analyse/Einblicke zum Fettabbaumarkt
Der nordamerikanische Markt zur Fettreduktion ist in sechs wichtige Segmente unterteilt, nämlich Typ, Anwendung, Geschlecht, Altersgruppe, Endbenutzer und Vertriebskanal.
Die in diesem Marktbericht abgedeckten Länder sind die USA, Kanada, Mexiko, Costa Rica, Dominikanische Republik, Panama, El Salvador, Guatemala, Honduras und Nicaragua.
Aufgrund der Präsenz wichtiger Marktteilnehmer im größten Verbrauchermarkt mit einem hohen BIP werden die USA voraussichtlich den nordamerikanischen Markt für Fettreduktion dominieren.
Der Länderabschnitt des Berichts enthält auch Angaben zu einzelnen marktbeeinflussenden Faktoren und Änderungen der Regulierung auf dem Inlandsmarkt, die sich auf die aktuellen und zukünftigen Trends des Marktes auswirken. Datenpunkte wie Neuverkäufe, Ersatzverkäufe, demografische Daten des Landes, Regulierungsgesetze und Import-/Exportzölle sind einige der wichtigsten Anhaltspunkte, die zur Prognose des Marktszenarios für einzelne Länder verwendet werden. Bei der Prognoseanalyse der Länderdaten werden auch die Präsenz und Verfügbarkeit nordamerikanischer Marken und ihre Herausforderungen aufgrund großer oder geringer Konkurrenz durch lokale und inländische Marken sowie die Auswirkungen der Vertriebskanäle berücksichtigt.
Wettbewerbsumfeld und Analyse der Marktanteile zur Fettreduzierung in Nordamerika
Die Wettbewerbslandschaft des nordamerikanischen Fettreduktionsmarktes bietet Einzelheiten zu den einzelnen Wettbewerbern. Zu den enthaltenen Einzelheiten gehören Unternehmensübersicht, Unternehmensfinanzen, erzielter Umsatz, Marktpotenzial, Investitionen in Forschung und Entwicklung, neue Marktinitiativen, Produktionsstandorte und -anlagen, Stärken und Schwächen des Unternehmens, Produkteinführung, Produktzulassungen, Produktbreite und -breite, Anwendungsdominanz und Produkttyp-Lebenslinienkurve. Die oben angegebenen Datenpunkte beziehen sich nur auf den Fokus des Unternehmens auf den nordamerikanischen Fettreduktionsmarkt.
Zu den wichtigsten Akteuren auf dem nordamerikanischen Markt für Fettreduktion zählen unter anderem Hironic Co Ltd, AbbVie Inc., Cynosure, Alma Lasers, Candela Corporation, Merz Pharma, Solta Medical (Tochtergesellschaft von Bausch & Lomb Incorporated), Cutera, MicroAire Surgical Instruments, LLC., Mentor Worldwide LLC, Venus Concept, Erchonia Corporation, BTL Group of Companies, Leaderma Inc., MÖLLER Medical, Fotona und Implantech.
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Inhaltsverzeichnis
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA FAT REDUCTION MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET APPLICATION COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 BRAND ANALYSIS
4.3.1 KYBELLA
5 INDUSTRY INSIGHTS:
6 NORTH AMERICA FAT REDUCTION MARKET, REGULATIONS
6.1 U.S.
6.1.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE:
6.1.2 POST-MARKETING SURVEILLANCE:
6.1.3 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES:
6.2 CANADA
6.2.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE
6.2.2 LICENSING AND REGISTRATION
6.2.3 POST EXPIRY OF PATENT REGIME
6.2.4 POST-MARKETING SURVEILLANCE
6.3 MEXICO
6.3.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE
6.3.2 REGULATORY APPROVAL AGENCIES
6.3.3 LICENSING AND REGISTRATION
6.3.4 POST-MARKETING SURVEILLANCE
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES
7.1.2 GROWING AESTHETIC CONSCIOUSNESS AND BEAUTY STANDARDS
7.1.3 GROWING TECHNOLOGICAL ADVANCEMENTS
7.1.4 DECREASED DISPARITY BETWEEN MEN AND WOMEN FOR AESTHETIC PROCEDURES
7.2 RESTRAINTS
7.2.1 HIGH COST OF PROCEDURES
7.2.2 INCREASED RISKS ASSOCIATED WITH THE PROCEDURES
7.2.3 PRODUCT RECALL
7.3 OPPORTUNITIES
7.3.1 CUSTOMIZED TREATMENT PLANS AND INTEGRATION WITH OTHER AESTHETIC PROCEDURES
7.3.2 BELIEF AND TREND OF FAT REDUCTION IN YOUNG ADULTS
7.3.3 FOCUS ON INCLUSIVITY AND DIVERSITY AND EXPANSION OF PRODUCT LINES
7.4 CHALLENGES
7.4.1 LONG-TERM EFFICACY AND SUSTAINABILITY
7.4.2 LONGER RECOVERY TIME OF THE PROCEDURE
8 NORTH AMERICA FAT REDUCTION MARKET, BY TYPE
8.1 OVERVIEW
8.2 SURGICAL FAT REDUCTION
8.2.1 LIPOSUCTION
8.2.1.1 BY TYPE
8.2.1.1.1 ULTRASOUND-ASSISTED LIPOSUCTION
8.2.1.1.2 LASER-ASSISTED LIPOSUCTION
8.2.1.1.3 TUMESCENT LIPOSUCTION
8.2.1.1.4 SUPER-WET TECHNIQUE
8.2.1.2 BY APPLICATION
8.2.1.2.1 ABDOMINAL FAT
8.2.1.2.2 THIGHS FAT
8.2.1.2.3 BUTTOCK FAT
8.2.1.2.4 UPPER-ARM FAT
8.2.1.2.5 FACIAL FAT-DEPOSITS
8.2.1.2.5.1 SUBMENTAL AREAS
8.2.1.2.5.2 MALAR
8.2.1.2.5.3 MANDIBULAR
8.2.1.2.6 KNEE FAT
8.2.2 SURGICAL REJUVENATION
8.2.2.1 FACE LIFT
8.2.2.2 NECK LIFT
8.2.3 CHIN IMPLANT
8.2.3.1 SILICONE CHIN IMPLANTS
8.2.3.2 OTHERS
8.2.4 PORUS IMPLANTS
8.2.4.1 TEFLON
8.2.4.2 GORE-TEX
8.2.4.3 MEDPORE IMPLANTS
8.3 NON-INVASIVE FAT REDUCTION
8.3.1 CRYOLIPOLYSIS
8.3.1.1 COOL SCULPTING
8.3.1.2 COOL SCULPTING ELITE
8.3.1.3 COOL TONE
8.3.1.4 OTHERS
8.3.1.4.1 ABDOMINAL FAT
8.3.1.4.2 THIGHS FAT
8.3.1.4.3 BUTTOCK FAT
8.3.1.4.4 UPPER-ARM FAT
8.3.1.4.5 FACIAL FAT-DEPOSITS
8.3.1.4.6 KNEE FAT
8.3.2 ULTRASOUND
8.3.2.1 INTERNAL ULTRASONIC LIPOSUCTION
8.3.2.2 EXTERNAL ULTRASONIC LIPOSUCTION
8.3.2.2.1 ABDOMINAL FAT
8.3.2.2.2 THIGHS FAT
8.3.2.2.3 BUTTOCK FAT
8.3.2.2.4 UPPER-ARM FAT
8.3.2.2.5 FACIAL FAT-DEPOSITS
8.3.2.2.6 KNEE FAT
8.3.3 RADIOFREQUENCY
8.3.3.1 ABDOMINAL FAT
8.3.3.2 THIGHS FAT
8.3.3.3 BUTTOCK FAT
8.3.3.4 UPPER-ARM FAT
8.3.3.5 FACIAL FAT-DEPOSITS
8.3.3.6 KNEE FAT
8.3.4 LOW LEVEL LASER THERAPY
8.3.4.1 ABDOMINAL FAT
8.3.4.2 THIGHS FAT
8.3.4.3 BUTTOCK FAT
8.3.4.4 UPPER-ARM FAT
8.3.4.5 FACIAL FAT-DEPOSITS
8.3.4.6 KNEE FAT
8.3.5 OTHERS
8.4 MINIMALLY INVASIVE
8.4.1 INJECTION LIPOLYSIS
8.4.1.1 DEOXYCHOLIC ACID INJECTIONS
8.4.1.1.1 KYBELLA/BELKYRA
8.4.1.1.1.1 FACIAL FAT-DEPOSITS
8.4.1.1.1.2 UPPER-ARM FAT
8.4.1.1.1.3 ABDOMINAL FAT
8.4.1.1.1.4 THIGHS FAT
8.4.1.1.1.5 KNEE FAT
8.4.1.1.1.6 BUTTOCK FAT
8.4.1.2 PHOSPHATIDYLCHOLINE
8.4.1.2.1 FACIAL FAT-DEPOSITS
8.4.1.2.2 UPPER-ARM FAT
8.4.1.2.3 ABDOMINAL FAT
8.4.1.2.4 THIGHS FAT
8.4.1.2.5 KNEE FAT
8.4.1.2.6 BUTTOCK FAT
8.4.2 OTHERS
9 NORTH AMERICA FAT REDUCTION MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 ABDOMINAL FAT
9.3 THIGHS FAT
9.4 BUTTOCK FAT
9.5 UPPER-ARM FAT
9.6 FACIAL FAT-DEPOSITS
9.6.1 SUBMENTAL AREAS
9.6.2 MANDIBULAR
9.6.3 MALAR
9.7 KNEE FAT
10 NORTH AMERICA FAT REDUCTION MARKET, BY GENDER
10.1 OVERVIEW
10.2 FEMALE
10.3 MALE
11 NORTH AMERICA FAT REDUCTION MARKET, BY AGE GROUP
11.1 OVERVIEW
11.2 ADULT
11.3 GERIATRIC
11.4 CHILD
12 NORTH AMERICA FAT REDUCTION MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.2.1 BY TYPE
12.2.1.1 PRIVATE
12.2.1.2 PUBLIC
12.2.2 BY CATEGORY
12.2.2.1 TIER 1
12.2.2.2 TIER 2
12.2.2.3 TIER 3
12.3 MULTISPECIALTY CLINICS
12.4 DERMATOLOGY CENTERS
12.5 MEDICAL SPAS AND BEAUTY CENTERS
12.6 OTHERS
13 NORTH AMERICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDERS
13.3 RETAIL SALES
13.4 THIRD PARTY DISTRIBUTORS
13.5 OTHERS
14 NORTH AMERICA FAT REDUCTION MARKET, BY COUNTRY
14.1 NORTH AMERICA
14.1.1 U.S.
14.1.2 CANADA
14.1.3 MEXICO
14.1.4 COSTA RICA
14.1.5 DOMINICAN REPUBLIC
14.1.6 PANAMA
14.1.7 EL SALVADOR
14.1.8 GUATEMALA
14.1.9 HONDURAS
14.1.10 NICARAGUA
15 COMPANY SHARE ANALYSIS: NORTH AMERICA
16 SWOT ANALYSIS
17 NORTH AMERICA FAT REDUCTION MARKET, COMPANY PROFILINGS
17.1 ABBVIE INC.
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENTS
17.2 CYNOSURE
17.2.1 COMPANY SNAPSHOT
17.2.2 PRODUCT PORTFOLIO
17.2.3 RECENT DEVELOPMENTS
17.3 ALMA LASERS
17.3.1 COMPANY SNAPSHOT
17.3.2 PRODUCT PORTFOLIO
17.3.3 RECENT DEVELOPMENT
17.4 CANDELA CORPORATION
17.4.1 COMPANY SNAPSHOT
17.4.2 PRODUCT PORTFOLIO
17.4.3 RECENT DEVELOPMENT
17.5 MERZ NORTH AMERICA, INC.
17.5.1 COMPANY SNAPSHOT
17.5.2 PRODUCT PORTFOLIO
17.5.3 RECENT DEVELOPMENTS
17.6 BLACK & BLACK SURGICAL
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENT
17.7 BTL GROUP OF COMPANIES
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENTS
17.8 BAUSCH HEALTH COMPANIES INC.
17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUE ANALYSIS
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENT
17.9 CUTERA
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 ERCHONIA CORPORATION
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 FOTONA
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 GENESIS BIOSYSTEMS, INC.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 HIRONIC CO., LTD.
17.13.1 COMPANY SNAPSHOT
17.13.2 REVENUE ANALYSIS
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENT
17.14 IMPLANTECH
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENTS
17.15 LEADERMA INC.
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 LYNTON LASERS LTD
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 MENTOR WORLDWIDE LLC (A PART OF JOHNSON & JOHNSON SERVICES, INC.)
17.17.1 COMPANY SNAPSHOT
17.17.2 REVENUE ANALYSIS
17.17.3 PRODUCT PORTFOLIO
17.17.4 RECENT DEVELOPMENT
17.18 MICROAIRE SURGICAL INSTRUMENTS, LLC.
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 MOLLER MEDICAL
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENT
17.2 POLLOGEN (A SUBSIDIARY OF LUMENIS BE LTD.)
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENT
17.21 SILIMED
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENTS
17.22 SURGIFORM INNOVATIVE SURGICAL PRODUCTS
17.22.1 COMPANY SNAPSHOT
17.22.2 PRODUCT PORTFOLIO
17.22.3 RECENT DEVELOPMENT
17.23 VENUS CONCEPT
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
Tabellenverzeichnis
TABLE 1 AVERAGE COST OF LIPOSUCTION ACROSS THE U.S.
TABLE 2 AVERAGE COSTS OF CHIN AUGMENTATION ACROSS THE U.S.
TABLE 3 NORTH AMERICA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 4 NORTH AMERICA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 5 NORTH AMERICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 6 NORTH AMERICA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 7 NORTH AMERICA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 8 NORTH AMERICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 9 NORTH AMERICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 10 NORTH AMERICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 11 NORTH AMERICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 12 NORTH AMERICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 13 NORTH AMERICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 14 NORTH AMERICA ULTRASOUND IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION)
TABLE 15 NORTH AMERICA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 16 NORTH AMERICA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 17 NORTH AMERICA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 18 NORTH AMERICA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 19 NORTH AMERICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 20 NORTH AMERICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 21 NORTH AMERICA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 22 NORTH AMERICA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 23 NORTH AMERICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 24 NORTH AMERICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 25 NORTH AMERICA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 26 NORTH AMERICA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 27 NORTH AMERICA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 28 NORTH AMERICA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 29 NORTH AMERICA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 30 NORTH AMERICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 31 U.S. FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 32 U.S. SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 33 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 34 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 35 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 36 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 37 U.S. FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 38 U.S. SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 39 U.S. SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 40 U.S. SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 41 U.S. CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 42 U.S. CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 43 U.S. CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 44 U.S. PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 45 U.S. PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 46 U.S. PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 47 U.S. NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 48 U.S. NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 49 U.S. NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 50 U.S. CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 51 U.S. CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 52 U.S. CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 53 U.S. CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 54 U.S.ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 55 U.S. ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 56 U.S. ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 57 U.S. ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 58 U.S. RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 59 U.S. LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 60 U.S. MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 61 U.S. INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 62 U.S. INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 63 U.S. INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 64 U.S. DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 65 U.S. DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 66 U.S. DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 67 U.S. KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 68 U.S. PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 69 U.S. FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 70 U.S. FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 71 U.S. FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 72 U.S. FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 73 U.S. FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 74 U.S. FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 75 U.S. FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 76 U.S. FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 77 U.S. FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 78 U.S. HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 79 U.S. HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 80 U.S. FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 81 CANADA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 82 CANADA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 83 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 84 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 85 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 86 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 87 CANADA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 88 CANADA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 89 CANADA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 90 CANADA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 91 CANADA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 92 CANADA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 93 CANADA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 94 CANADA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 95 CANADA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 96 CANADA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 97 CANADA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 98 CANADA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 99 CANADA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 100 CANADA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 101 CANADA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 102 CANADA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 103 CANADA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 104 CANADAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 105 CANADA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 106 CANADA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 107 CANADA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 108 CANADA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 109 CANADA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 110 CANADA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 111 CANADA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 112 CANADA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 113 CANADA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 114 CANADA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 115 CANADA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 116 CANADA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 117 CANADA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 118 CANADA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 119 CANADA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 120 CANADA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 121 CANADA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 122 CANADA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 123 CANADA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 124 CANADA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 125 CANADA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 126 CANADA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 127 CANADA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 128 CANADA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 129 CANADA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 130 CANADA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 131 MEXICO FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 132 MEXICO SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 133 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 134 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 135 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 136 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 137 MEXICO FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 138 MEXICO SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 139 MEXICO SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 140 MEXICO SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 141 MEXICO CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 142 MEXICO CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 143 MEXICO CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 144 MEXICO PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 145 MEXICO PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 146 MEXICO PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 147 MEXICO NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 148 MEXICO NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 149 MEXICO NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 150 MEXICO CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 151 MEXICO CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 152 MEXICO CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 153 MEXICO CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 154 MEXICOULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 155 MEXICO ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 156 MEXICO ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 157 MEXICO ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 158 MEXICO RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 159 MEXICO LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 160 MEXICO MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 161 MEXICO INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 162 MEXICO INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 163 MEXICO INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 164 MEXICO DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 165 MEXICO DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 166 MEXICO DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 167 MEXICO KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 168 MEXICO PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 169 MEXICO FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 170 MEXICO FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 171 MEXICO FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 172 MEXICO FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 173 MEXICO FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 174 MEXICO FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 175 MEXICO FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 176 MEXICO FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 177 MEXICO FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 178 MEXICO HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 179 MEXICO HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 180 MEXICO FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 181 COSTA RICA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 182 COSTA RICA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 183 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 184 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 185 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 186 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 187 COSTA RICA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 188 COSTA RICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 189 COSTA RICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 190 COSTA RICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 191 COSTA RICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 192 COSTA RICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 193 COSTA RICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 194 COSTA RICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 195 COSTA RICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 196 COSTA RICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 197 COSTA RICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 198 COSTA RICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 199 COSTA RICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 200 COSTA RICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 201 COSTA RICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 202 COSTA RICA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 203 COSTA RICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 204 COSTA RICAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 205 COSTA RICA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 206 COSTA RICA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 207 COSTA RICA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 208 COSTA RICA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 209 COSTA RICA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 210 COSTA RICA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 211 COSTA RICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 212 COSTA RICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 213 COSTA RICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 214 COSTA RICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 215 COSTA RICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 216 COSTA RICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 217 COSTA RICA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 218 COSTA RICA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 219 COSTA RICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 220 COSTA RICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 221 COSTA RICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 222 COSTA RICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 223 COSTA RICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 224 COSTA RICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 225 COSTA RICA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 226 COSTA RICA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 227 COSTA RICA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 228 COSTA RICA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 229 COSTA RICA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 230 COSTA RICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 231 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 232 DOMINICAN REPUBLIC SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 233 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 234 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 235 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 236 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 237 DOMINICAN REPUBLIC FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 238 DOMINICAN REPUBLIC SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 239 DOMINICAN REPUBLIC SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 240 DOMINICAN REPUBLIC SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 241 DOMINICAN REPUBLIC CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 242 DOMINICAN REPUBLIC CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 243 DOMINICAN REPUBLIC CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 244 DOMINICAN REPUBLIC PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 245 DOMINICAN REPUBLIC PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 246 DOMINICAN REPUBLIC PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 247 DOMINICAN REPUBLIC NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 248 DOMINICAN REPUBLIC NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 249 DOMINICAN REPUBLIC NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 250 DOMINICAN REPUBLIC CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 251 DOMINICAN REPUBLIC CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 252 DOMINICAN REPUBLIC CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 253 DOMINICAN REPUBLIC CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 254 DOMINICAN REPUBLICULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 255 DOMINICAN REPUBLIC ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 256 DOMINICAN REPUBLIC ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 257 DOMINICAN REPUBLIC ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 258 DOMINICAN REPUBLIC RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 259 DOMINICAN REPUBLIC LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 260 DOMINICAN REPUBLIC MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 261 DOMINICAN REPUBLIC INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 262 DOMINICAN REPUBLIC INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 263 DOMINICAN REPUBLIC INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 264 DOMINICAN REPUBLIC DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 265 DOMINICAN REPUBLIC DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 266 DOMINICAN REPUBLIC DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 267 DOMINICAN REPUBLIC KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 268 DOMINICAN REPUBLIC PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 269 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 270 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 271 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 272 DOMINICAN REPUBLIC FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 273 DOMINICAN REPUBLIC FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 274 DOMINICAN REPUBLIC FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 275 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 276 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 277 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 278 DOMINICAN REPUBLIC HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 279 DOMINICAN REPUBLIC HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 280 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 281 PANAMA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 282 PANAMA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 283 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 284 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 285 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 286 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 287 PANAMA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 288 PANAMA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 289 PANAMA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 290 PANAMA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 291 PANAMA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 292 PANAMA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 293 PANAMA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 294 PANAMA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 295 PANAMA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 296 PANAMA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 297 PANAMA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 298 PANAMA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 299 PANAMA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 300 PANAMA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 301 PANAMA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 302 PANAMA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 303 PANAMA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 304 PANAMAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 305 PANAMA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 306 PANAMA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 307 PANAMA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 308 PANAMA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 309 PANAMA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 310 PANAMA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 311 PANAMA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 312 PANAMA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 313 PANAMA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 314 PANAMA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 315 PANAMA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 316 PANAMA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 317 PANAMA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 318 PANAMA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 319 PANAMA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 320 PANAMA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 321 PANAMA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 322 PANAMA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 323 PANAMA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 324 PANAMA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 325 PANAMA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 326 PANAMA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 327 PANAMA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 328 PANAMA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 329 PANAMA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 330 PANAMA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 331 EL SALVADOR FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 332 EL SALVADOR SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 333 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 334 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 335 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 336 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 337 EL SALVADOR FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 338 EL SALVADOR SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 339 EL SALVADOR SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 340 EL SALVADOR SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 341 EL SALVADOR CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 342 EL SALVADOR CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 343 EL SALVADOR CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 344 EL SALVADOR PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 345 EL SALVADOR PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 346 EL SALVADOR PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 347 EL SALVADOR NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 348 EL SALVADOR NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 349 EL SALVADOR NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 350 EL SALVADOR CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 351 EL SALVADOR CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 352 EL SALVADOR CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 353 EL SALVADOR CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 354 EL SALVADORULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 355 EL SALVADOR ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 356 EL SALVADOR ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 357 EL SALVADOR ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 358 EL SALVADOR RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 359 EL SALVADOR LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 360 EL SALVADOR MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 361 EL SALVADOR INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 362 EL SALVADOR INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 363 EL SALVADOR INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 364 EL SALVADOR DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 365 EL SALVADOR DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 366 EL SALVADOR DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 367 EL SALVADOR KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 368 EL SALVADOR PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 369 EL SALVADOR FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 370 EL SALVADOR FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 371 EL SALVADOR FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 372 EL SALVADOR FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 373 EL SALVADOR FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 374 EL SALVADOR FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 375 EL SALVADOR FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 376 EL SALVADOR FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 377 EL SALVADOR FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 378 EL SALVADOR HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 379 EL SALVADOR HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 380 EL SALVADOR FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 381 GUATEMALA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 382 GUATEMALA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 383 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 384 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 385 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 386 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 387 GUATEMALA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 388 GUATEMALA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 389 GUATEMALA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 390 GUATEMALA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 391 GUATEMALA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 392 GUATEMALA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 393 GUATEMALA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 394 GUATEMALA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 395 GUATEMALA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 396 GUATEMALA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 397 GUATEMALA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 398 GUATEMALA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 399 GUATEMALA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 400 GUATEMALA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 401 GUATEMALA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 402 GUATEMALA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 403 GUATEMALA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 404 GUATEMALAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 405 GUATEMALA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 406 GUATEMALA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 407 GUATEMALA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 408 GUATEMALA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 409 GUATEMALA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 410 GUATEMALA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 411 GUATEMALA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 412 GUATEMALA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 413 GUATEMALA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 414 GUATEMALA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 415 GUATEMALA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 416 GUATEMALA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 417 GUATEMALA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 418 GUATEMALA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 419 GUATEMALA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 420 GUATEMALA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 421 GUATEMALA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 422 GUATEMALA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 423 GUATEMALA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 424 GUATEMALA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 425 GUATEMALA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 426 GUATEMALA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 427 GUATEMALA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 428 GUATEMALA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 429 GUATEMALA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 430 GUATEMALA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 431 HONDURAS FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 432 HONDURAS SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 433 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 434 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 435 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 436 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 437 HONDURAS FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 438 HONDURAS SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 439 HONDURAS SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 440 HONDURAS SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 441 HONDURAS CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 442 HONDURAS CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 443 HONDURAS CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 444 HONDURAS PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 445 HONDURAS PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 446 HONDURAS PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 447 HONDURAS NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 448 HONDURAS NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 449 HONDURAS NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 450 HONDURAS CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 451 HONDURAS CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 452 HONDURAS CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 453 HONDURAS CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 454 HONDURASULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 455 HONDURAS ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 456 HONDURAS ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 457 HONDURAS ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 458 HONDURAS RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 459 HONDURAS LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 460 HONDURAS MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 461 HONDURAS INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 462 HONDURAS INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 463 HONDURAS INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 464 HONDURAS DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 465 HONDURAS DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 466 HONDURAS DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 467 HONDURAS KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 468 HONDURAS PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 469 HONDURAS FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 470 HONDURAS FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 471 HONDURAS FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 472 HONDURAS FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 473 HONDURAS FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 474 HONDURAS FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 475 HONDURAS FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 476 HONDURAS FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 477 HONDURAS FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 478 HONDURAS HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 479 HONDURAS HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 480 HONDURAS FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 481 NICARAGUA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 482 NICARAGUA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 483 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 484 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 485 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 486 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 487 NICARAGUA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 488 NICARAGUA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 489 NICARAGUA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 490 NICARAGUA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 491 NICARAGUA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 492 NICARAGUA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 493 NICARAGUA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 494 NICARAGUA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 495 NICARAGUA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 496 NICARAGUA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 497 NICARAGUA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 498 NICARAGUA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 499 NICARAGUA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 500 NICARAGUA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 501 NICARAGUA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 502 NICARAGUA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 503 NICARAGUA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 504 NICARAGUAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 505 NICARAGUA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 506 NICARAGUA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 507 NICARAGUA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 508 NICARAGUA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 509 NICARAGUA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 510 NICARAGUA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 511 NICARAGUA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 512 NICARAGUA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 513 NICARAGUA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 514 NICARAGUA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 515 NICARAGUA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 516 NICARAGUA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 517 NICARAGUA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 518 NICARAGUA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 519 NICARAGUA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 520 NICARAGUA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 521 NICARAGUA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 522 NICARAGUA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 523 NICARAGUA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 524 NICARAGUA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 525 NICARAGUA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 526 NICARAGUA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 527 NICARAGUA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 528 NICARAGUA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 529 NICARAGUA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 530 NICARAGUA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
Abbildungsverzeichnis
FIGURE 1 NORTH AMERICA FAT REDUCTION MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA FAT REDUCTION MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA FAT REDUCTION MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA FAT REDUCTION MARKET: COUNTRY VS. REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA FAT REDUCTION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA FAT REDUCTION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA FAT REDUCTION MARKET: MULTIVARIATE MODELLING
FIGURE 8 NORTH AMERICA FAT REDUCTION MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA FAT REDUCTION MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA FAT REDUCTION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 NORTH AMERICA FAT REDUCTION MARKET: SEGMENTATION
FIGURE 12 INCREASING DEMAND FOR NON-INVASIVE AND MINIMALLY INVASIVE AESTHETIC PROCEDURES IS EXPECTED TO DRIVE THE NORTH AMERICA FAT REDUCTION MARKET GROWTH IN THE FORECAST PERIOD FROM 2023 TO 2033
FIGURE 13 THE SURGICAL FAT REDUCTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA FAT REDUCTION MARKET IN 2023 & 2033
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA FAT REDUCTION MARKET
FIGURE 15 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, 2022
FIGURE 16 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, 2023-2033 (USD MILLION)
FIGURE 17 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, CAGR (2023-2033)
FIGURE 18 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, LIFELINE CURVE
FIGURE 19 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, 2022
FIGURE 20 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, 2023-2033 (USD MILLION)
FIGURE 21 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, CAGR (2023-2033)
FIGURE 22 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 23 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, 2022
FIGURE 24 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, 2023-2033 (USD MILLION)
FIGURE 25 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, CAGR (2023-2033)
FIGURE 26 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, LIFELINE CURVE
FIGURE 27 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, 2022
FIGURE 28 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, 2023-2033 (USD MILLION)
FIGURE 29 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, CAGR (2023-2033)
FIGURE 30 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 31 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, 2022
FIGURE 32 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, 2023-2033 (USD MILLION)
FIGURE 33 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, CAGR (2023-2033)
FIGURE 34 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, LIFELINE CURVE
FIGURE 35 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 36 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, 2023-2033 (USD MILLION)
FIGURE 37 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2033)
FIGURE 38 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 39 NORTH AMERICA FAT REDUCTION MARKET: SNAPSHOT (2022)
FIGURE 40 NORTH AMERICA FAT REDUCTION MARKET: BY COUNTRY (2022)
FIGURE 41 NORTH AMERICA FAT REDUCTION MARKET: BY COUNTRY (2023 & 2033)
FIGURE 42 NORTH AMERICA FAT REDUCTION MARKET: BY COUNTRY (2022 & 2033)
FIGURE 43 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE (2023-2033)
FIGURE 44 NORTH AMERICA FAT REDUCTION MARKET: COMPANY SHARE 2022 (%)
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
